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Approximately 20% of pregnant women report elevated depressive symptoms.1 In low-
income, African American women that percentage was doubled (42%).2 Women with 
elevated prenatal depressive symptoms are more likely to have smaller fetuses, premature 
births, and low birth weight infants.3,4 In 2012, 16.5% of African American women 
experienced a premature birth compared to the national average of 11.5%.5 Predictors for 
prenatal depressive symptoms include young age, single marital status, unemployment, 
smoking, poor overall health, low education, history of depression,6 history of childhood 
sexual abuse,7 lower levels of support,8 and elevated levels of anxiety.9 Neonates whose 
mothers have elevated prenatal depressive symptoms are at risk for neurobehavioral 
dysregulation as reflected by less positive affect, lower vagal tone, and elevated cortisol 
levels.3 Prenatal depressive symptoms contribute to altered patterns of mother-infant 
relationships, such as the mother’s expressed lack of desire for close contact with her infant, 
lack of satisfaction with being a mother, hostility, and feelings of resentment toward her 
infant.10
The biological mechanisms underlying this health disparity in pregnant African American 
women are poorly understood. In order to identify women at risk for prenatal depression, 
providers screen pregnant women using interview techniques or validated screening 
questionnaires.11 The American College of Obstetrics and Gynecology, however, does not 
recommend universal screening of pregnant or postpartum women for depression but 
recommends screening per the providers’ discretion and preference.12 Understanding the 
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biological pathway for prenatal depression in African American women may increase the 
capacity for identification of women at risk before symptoms are present. Understanding this 
biological pathway may also enhance opportunities for providing needed treatment of 
vulnerable mothers. Thus improving infant outcomes. Previous reports have suggested 
oxytocin may be part of the potential biological pathways involved in perinatal 
depression.13–21 Accordingly, we hypothesized that oxytocin levels may predict perinatal 
depression.
Oxytocin is a nonapeptide hormone synthesized primarily in the brain, but also in peripheral 
organs (uterus, placenta, amnion, corpus luteum, testis, and heart). Oxytocin is released in 
response to various stimuli including social interactions, vaginal stimulation, labor 
progression, and lactation.15 Oxytocin release promotes actions relating to the development 
of social attachments.22,23 Oxytocin promotes a desire to touch and be touched, bonding 
between two people such as husband and wife or mother and child, and initiation of 
maternal behaviors.22–26 Low levels of oxytocin have been linked to altered patterns of 
mother-infant interactions including less touch,14 whereas high levels of oxytocin have been 
associated with greater mother-newborn interactions including increased gaze, vocalization, 
positive affect, and touch.13,18 Finally, low oxytocin levels in pregnancy may be predictive 
of postpartum depressive symptoms.21 However, oxytocin has not been explored during 
pregnancy in an urban African American sample. In a sample of urban African American 
women, we examined factors potentially associated with prenatal depressive symptoms 
including plasma oxytocin levels, birth weight/prematurity, demographics, anxiety, support 
from the infant’s father, and maternal health history.
Materials and Method
Design
The data for this secondary analysis were obtained from a larger longitudinal study of 
pregnant African American women. The larger study was designed to examine stress, 
pregnancy, and birth outcomes. Data were collected twice during pregnancy (15 – 22 and 25 
– 37 weeks). Birth data were obtained from medical records.
Setting
Participants were recruited from a large medical center in Chicago, Illinois. Women were 
recruited after their standard prenatal care appointment.
Subjects
Subjects included 57 pregnant African American women at a prenatal care appointment 
between 15 – 22 weeks gestation. Women were invited into the study if they were 18 years 
of age or older, had a singleton pregnancy, and were able to read and write English. Per the 
larger longitudinal study, subjects with hypertension, pre-gestational diabetes, human 
immunodeficiency virus (HIV), autoimmune disorders, a multiple gestation pregnancy, or 
receiving medications such as dexamethasone, betamethasone, or inhaled steroid were 
excluded from the study. These characteristics may affect the larger study outcomes of 
maternal stress and pregnancy.
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Data collected included medical record review for birth outcomes (e.g. gestational age at 
birth and birth weight), blood samples for plasma oxytocin analysis, and self-reported 
questionnaires.
Plasma oxytocin was analyzed in duplicate using enzyme-linked immunoassay (ELISA) 
(Enzo Life Sciences). Oxytocin detection levels were 15.6 pg/ml to 1000 pg/ml.27 The intra-
assay coefficient of variability was 9.7% to 30% and an inter-assay coefficient of variability 
was 4.6% to 8.6%.
Self-reported data included a socio-demographic questionnaire in which women indicated 
their age, marital status, education, household income, and family involvement that included 
support of the infant’s father during pregnancy. Additionally, participants completed 
previously validated instruments to assess state anxiety and prenatal depressive symptoms,
State anxiety was measured by the State-Trait Anxiety Inventory (STAI).28 The state 
subscale of the STAI consists of 20 items (e.g., feeling happy, calm, jittery, upset, confused) 
rated on a 4-point Likert scale (1 = not at all and 4 = very much so) with scores ranging from 
20 – 80. A higher score is associated with higher levels of anxiety.28 The Cronbach’s alpha 
for this study was 0.91.
Prenatal depressive symptoms were measured using the Center for Epidemiologic Studies 
Depression Scale (CESD).29,30 The CESD consists of 20 depressive symptoms (e.g., lonely, 
sad, restless) rated on a 4-point Likert scale (0 = rarely or none of the time to 3 = most or all 
of the time) with scores ranging from 0 – 60. A score of 16 or greater indicates clinically 
elevated depressive symptoms.31 For this study, the Cronbach’s alpha was 0.84.
Procedures
The Institutional Review Board at the University of Illinois at Chicago approved this study. 
Pregnant African American women between 15 – 22 weeks gestation were invited to 
participate. After giving informed consent, participants completed the packet of 
questionnaires in a private room after their prenatal visit. No stimuli were present that may 
affect oxytocin levels (such as pictures of loved ones, baby toys/dolls, or pregnancy/baby 
related magazines). On the same day, the participant’s blood was drawn into an 
ethylenediaminetetracetic acid (EDTA) sterile tube (10 ml) and placed on ice. This was 
completed in the afternoon (1:00 p.m. – 5:00 p.m.) for consistency. The samples were 
transported on ice, centrifuged (1500 × g, 15 minutes), and aliquoted within 3 hours of 
withdrawal. Once plasma was aliquoted, the samples were stored at −80°C for batch 
analysis. All assays were conducted according to manufacturer specifications, but samples 
were not extracted. Participants were given a $25 gift card for their participation and time. 
Three participants did not return to the clinic between 25 – 37 weeks and two additional 
participants delivered prior to the second data collection time. A member of the research 
team completed a maternal medical record review prenatally and postpartum (for birth data). 
The participants were not contacted after birth.
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Descriptive statistics were generated to describe sample characteristics. Paired sample t-tests 
were computed to analyze changes in depressive symptoms and oxytocin between the first 
and second data collection. Independent t-tests were computed to examine the relationship 
between prenatal depressive symptoms and gravida status (primigravida versus 
multigravida). Spearman’s correlation coefficient was computed to examine the 
relationships among depressive symptoms, raw oxytocin levels, birth weight, gestational age 
at birth, and anxiety. Analysis of variance was computed to examine depressive symptoms 
and support of the infant’s father during the pregnancy.
Due to the wide range of oxytocin values previously reported in the literature,18 after 
continuous data analysis, raw oxytocin values were categorized as low, normal, and high. 
These category distinctions were based on previous reports17 and graphical cut points. A 
one-way analysis of variance (ANOVA) was computed to examine the relationships 
between oxytocin categories and prenatal depressive symptoms, birth weight, and 
gestational age at birth.
Results
Sample Characteristics
The average age of women in our sample was 23.4 (SD = 4.8) years, and ages ranged 
between 18 and 36 years. Subjects’ predominately delivered their infants at term with an 
average gestational age at birth of 38.6 (SD = 2.5) weeks, with ranges from 25 – 41 weeks. 
The majority of women were multigravidas (75%). Most subjects did not have a college 
degree (86%) and had an annual income less than $30,000 (85%). A majority of women 
(70%) reported the baby’s father was fully involved with the pregnancy. At the first time 
point subjects reported moderate levels of anxiety (STAI = 35, SD = 11), and 35% had 
elevated depressive symptoms (score ≥ 16 on CESD). No significant differences were found 
in state anxiety or depressive symptoms between the first and second time point (see Table 
1).
The average oxytocin value was 504 pg/ml, SD = 284.2, with a range between 170 and 2056 
pg/ml. No significant differences in oxytocin levels were found between the first and second 
time point. Therefore, we conducted the remaining analysis only with the first data point. 
Oxytocin data was divided into low (<400 pg/ml), medium (401–700 pg/ml), and high 
(>701 pg/ml) categories, based on the distribution of the data and corroborated by previous 
reports on oxytocin.17,18,32 The low category represented the lower 35%, while the high 
category represented the upper 10%. The mean depressive symptoms in the low, normal, 
and high oxytocin categories were 15.6, 12.4, and 5.3 respectively (see Table 2).
Factors Associated with Prenatal Depressive Symptoms, Oxytocin and Birth Weights
Depressive symptoms were higher in multigravidas (t(51) = −2.37, p = 0.02), women with 
higher anxiety (r(47) = 0.71, p = 0.001), women who delivered their infants at an earlier 
gestational age (r(51) = −0.29, p = 0.04), and those without the support of the infant’s father 
(F(4,48) = 2.676, p = 0.04). There was no statistical relationship between depressive 
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symptoms and birth weight (r(50) = −0.21, p = 0.15) or raw oxytocin levels(r(51) = −0.10, p = 
0.53). After depressive symptoms were dichotomized into elevated and non-elevated (CESD 
score ≥ 16), there continued to be no statistical relationship between elevated depressive 
symptoms and birth weight (t(48) = 1.4, p = 0.17), or raw oxytocin levels (t(48) = 0.60, p = 
0.55). In addition there was no relationship between the group of participants with elevated 
depressive symptoms (CESD score ≥ 16) and oxytocin category (low, medium, or high) 
(X2(2, N = 50) = 3.5, p = 0.18).
Oxytocin categories (low, medium, or high) and depressive symptoms (CESD scores) were 
related. Depressive symptoms were higher in women with low levels of oxytocin (n = 17) 
compared to women with high levels of oxytocin (n = 5) (F(2,47) = 3.3, p = 0.05, Fisher’s 
Least Significant Difference (LSD) = 0.015) (see Figure 1).
In addition, women with low levels of oxytocin also tended to be more likely to have infants 
with lower birth weights compared to women categorized as having medium and high levels 
of oxytocin (F(2,47) = 2.9, p = 0.06, LSD = 0.037, 0.063 respectively); although this 
difference in birth weights is not clinically significant (see Figure 2). There was no 
relationship between oxytocin categories (low, medium, or high) and gestational age at birth.
Discussion
In pregnant African American, primarily low-income women, a large percentage (35%) 
experienced elevated prenatal depressive symptoms. Depressive symptoms were higher in 
multigravidas, women who reported greater anxiety, and in women without involvement 
from the baby’s father. In addition, women with elevated prenatal depressive symptoms 
more frequently had low levels of prenatal oxytocin and earlier gestational ages at birth.
The prevalence of elevated prenatal depressive symptoms is consistent with other studies of 
pregnant African American women33,34 and low income mothers.35,36 Previous reports also 
identified anxiety and depression as comorbid conditions.37 In addition, we found the mean 
anxiety levels in our sample (STAI mean = 34) were similar to other reports from low–
income, predominately African American pregnant women (STAI mean = 39).38 Other 
researchers have found that women with low levels of social support also reported higher 
levels of prenatal depressive symptoms.39,40 Specifically, the social support of the infant’s 
father has been identified as a protective factor for elevated postpartum depressive 
symptoms.41–43
The wide range (170 – 2056 pg/ml) of raw oxytocin levels reported in this investigation is 
consistent with previous studies using a similar methodology.13,44 The range of possible 
oxytocin values between our sample and other reports are comparable with oxytocin values 
in some cases exceeding 2000 pg/ml. The mean value of oxytocin from our sample was 504 
pg/ml, compared to values of approximately 300 pg/ml, which are typical of other 
populations using identical measures.13,44 The comparatively high levels of oxytocin 
measured in this study may reflect physiological coping mechanisms associated with 
lifestyle in this vulnerable low-income pregnant African American population.
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We identified a relationship between low oxytocin category and increased prenatal 
depressive symptoms. Prior reports have identified lower prenatal oxytocin values as a risk 
factor for postpartum depressive symptoms.21 In addition, the literature provides support 
that higher prenatal oxytocin values are related to positive postpartum maternal behaviors 
such as gaze, affect, touch, and vocalization during the first month postpartum.13 Higher 
postpartum oxytocin levels have been associated with positive affectionate parenting 
including vocalization, positive affect, and touch.16 In a non-pregnant population, lower 
oxytocin has been identified in individuals with greater depressive symptoms.19,20
Women with low prenatal oxytocin levels delivered infants who tended to have lower birth 
weights when compared to mothers with medium and high oxytocin levels. The mean 
difference in birth weight was not clinically significant, but it raises the question of the 
potential relationship between these factors.
Study Limitations
Limitations of this study include 1) small sample size, 2) limited variables, and 3) inclusion 
of only African American women. The sample size of 57 women included 6 women who 
had a premature birth. Further analysis with premature birth, prenatal depressive symptoms, 
and oxytocin were limited based on the small number of premature births. Second, because 
this study was a secondary analysis of existing data, we were limited by its design and the 
data collected. For example, longitudinal data from the postpartum period may have 
provided a more complete understanding of the ways these factors are associated. The third 
limitation is based on the homogeneity of the sample. The urban, low income, African 
American women in our sample may have experienced unique life events affecting their 
oxytocin levels and their self-report of prenatal depressive symptoms. This sample was 
chosen due to the known increased risk of prenatal depression in African American women, 
yet this limits the generalizability of these results.
Conclusions
A large percentage of pregnant African American urban women, report elevated prenatal 
depressive symptoms. There are many factors related to elevated prenatal depressive 
symptoms and oxytocin may be one of the biological pathways explaining this increased 
risk. Understanding the biologic pathway of prenatal depressive symptoms may also explain 
other pregnancy health disparities in African American women such as premature birth. 
Identifying the biological pathway for depressive symptoms might allow for improved 
identification and future treatment. Early identification of pregnant women at risk for 
depressive symptoms may improve known sequelae such as maternal health, mother-infant 
interactions, and infant development.45,46
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Prenatal Depressive Symptoms and Oxytocin. Women with low oxytocin levels had more 
depressive symptoms compared to women with high oxytocin levels. Error bars represent 
one standard error from the mean. CESD: Center for Epidemiologic Studies Depression 
scale. Sample size for the groups is as follows: less than 400, n = 18; 401–700, n = 27; 
greater than 701, n = 5.
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Infant Birth Weight and Oxytocin. The relationship between prenatal oxytocin category and 
infant birth weight trended toward significance. The relationship between infant birth weight 
and raw prenatal oxytocin values was not significant. Error bars represent one standard error 
from the mean. Sample size for the groups is as follows: less than 400, n = 17; 401–700, n = 
27; greater than 701, n = 5.
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Maternal age (years) 23.4 (4.8)
Gestational age (weeks)
   First data point 19.5 (2.5)
   Second data point 29.7 (3.1)
   Birth 38.6 (2.5)
Infant birth weight (grams) 3105 (690)
Multigravida 75%
Education
   % Less than High School 21%
   % High School Graduate 24%
   % Some College 44%
   % College Graduate 11%
Marital Status
   Single 84%
   Married 14%
   Separated 2%
Income less than 30,000 79%
Baby’s father involvement
   Not involved 11%
   Moderately involved 19%
   Fully involved 70%
State Anxiety (STAI)
   First data point 34.7 (11)
   Second data point 32.8 (10)
Depressive Symptoms (CESD)
   First data point 13 (8.6)
   Second data point 12 (9.0)
CESD score 16 or greater
   First data point 35%
   Second data point 33%
Note. STAI = State Trait Anxiety Inventory. CESD = Center for Epidemiology Studies – Depressive Scale
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Sample Means 504 (284) 13.1 (8.6) 3105 (690) 50
Categories of Oxytocin
   Low Oxytocin (<400) 304 (70) 15.6 (10.7) 2769 (811) 18
   Medium Oxytocin (401–700) 508 (73) 12.4 (7.1) 3223 (542) 27
   High Oxytocin (>701) 1030 (475) 5.3 (4.6) 3350 (791) 5
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